We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Genetically Engineered Mosquitoes Prevent Transmission of Dengue Fever

By LabMedica International staff writers
Posted on 08 Mar 2010
Researchers have genetically engineered a line of mosquitoes so that the females of the next generation, which normally carry and transmit the dengue fever virus, are unable to fly and die before they can spread the disease or reproduce.

The mosquito Aedes aegypti is the major vector of dengue and dengue hemorrhagic fever, which are increasing public health problems with an estimated 50-100 million new infections each year. More...
The virus is spread by the bite of the female mosquito, and currently no vaccine or treatment is available.

Eliminating the insect vector could be an effective way of controlling the disease. To this end, investigators from the University of California, Irvine (USA) and the biotechnology company Oxitec, Ltd. (Oxford, United Kingdom) have explored the possibility of using genetic engineering techniques to reduce or eliminate transmission of the disease.

In an article published in the February 22, 2010, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) they reported that they had succeeded in engineering male mosquitoes to carry one or more genes that result in the females of the next generation being unable to fly. Flightless females die quickly in the wild, and curtailing the number of mosquitoes seriously disrupts dengue transmission. Males of the strain can fly but do not bite or convey disease. These strains therefore eliminate the need for sterilization by irradiation, permit male-only release, and enable the release of eggs instead of adults.

"The technology is completely species-specific, as the released males will mate only with females of the same species,” said senior author Dr. Luke Alphey, chief scientific officer at Oxitec. "It is far more targeted and environmentally friendly than approaches dependent upon the use of chemical spray insecticides, which leave toxic residue. Another attractive feature of this method is that it is egalitarian: All people in the treated areas are equally protected, regardless of their wealth, power, or education.”

Related Links:
University of California, Irvine
Oxitec


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.